Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Neurology · Idiopathic Small Fiber Neuropathy

Beyond 'Idiopathic': Uncovering Hidden Causes

At a Glance

A diagnosis of idiopathic small fiber neuropathy (SFN) means standard tests haven't found the cause, but advanced screening often can. Deeper testing for early prediabetes, Sjögren's syndrome, and novel antibodies like TS-HDS and FGFR3 can reveal treatable hidden drivers of nerve damage.

The diagnosis of “idiopathic” Small Fiber Neuropathy is often a starting point, not a final destination. In many cases, “idiopathic” simply means the underlying cause has not yet been identified by standard medical screening. Finding the specific driver of your nerve damage is critical because it offers the best chance to halt or even reverse the progression of the disease [1][2].

Metabolic “Stealth” Causes

Metabolic issues are the most common hidden drivers of small fiber damage. Even if your routine physical didn’t flag you for diabetes, more specialized tests might reveal a problem.

  • The OGTT vs. HbA1c: Most doctors use the HbA1c test to screen for diabetes. However, research shows that HbA1c often fails to catch early-stage glucose impairment [3]. The 2-hour Oral Glucose Tolerance Test (OGTT)—where you drink a sugar solution and have your blood drawn at intervals—is significantly more sensitive for detecting “prediabetes” in SFN patients [3][4].
  • Metabolic Syndrome & Sphingolipids: Emerging research has identified neurotoxic fats called 1-deoxy-sphingolipids that accumulate in people with metabolic syndrome (a cluster of high blood pressure, high blood sugar, and high triglycerides) [5]. These “stealth” toxins can directly damage mitochondria in your small nerve fibers, causing them to degrade [6][7].

Autoimmune and Inflammatory Drivers

In some patients, the immune system mistakenly attacks the small nerve fibers. These causes are particularly common in cases where symptoms are “patchy” or not just in the feet.

  • Sjögren’s Syndrome: This is a leading immune-mediated cause of SFN [8]. While it is famous for causing dry eyes and mouth, many SFN patients have the nerve damage before any dryness develops [8].
  • Celiac Disease and Sarcoidosis: Both of these inflammatory conditions can trigger small fiber loss even if you don’t have the “classic” symptoms like digestive distress or lung issues [9][10].

The “New” Antibodies: TS-HDS and FGFR3

For patients with no other known cause, doctors may test for two specialized autoantibodies: TS-HDS and FGFR3. These are found in up to 44% to 55% of previously “unexplained” cases [11][12].

  • Significance: These markers are often associated with an acute onset (symptoms starting quickly) and a non-length-dependent (patchy) pattern of pain [13][11].
  • Treatment Shifts: Finding these antibodies may change your management plan. Some retrospective studies have shown that patients with these markers may improve with immunotherapy (such as IVIG), although large clinical trials have shown mixed results and more research is needed [11][12][14].

A Proactive Search

If your SFN is currently labeled “idiopathic,” it is worth discussing a “deeper dive” with your neurologist. Identifying a metabolic or immune driver allows for targeted treatments—like aggressive blood sugar management or immune-modulating therapy—rather than just treating the pain [2].

Common questions in this guide

Why do I need a glucose tolerance test if my HbA1c is normal?
The standard HbA1c test can miss early-stage blood sugar issues that damage nerves. A 2-hour oral glucose tolerance test (OGTT) is much more sensitive at detecting hidden prediabetes, which is one of the most common metabolic causes of small fiber neuropathy.
What are TS-HDS and FGFR3 antibodies?
These are specialized autoantibodies found in nearly half of patients whose small fiber neuropathy was previously labeled as unexplained. Testing positive for these markers suggests your nerve pain has an autoimmune driver and may respond to immune-modulating treatments.
Can Sjögren's syndrome cause nerve pain before dry eyes start?
Yes, many patients with Sjögren's syndrome experience small fiber nerve damage before they ever develop the classic symptoms of dry eyes or a dry mouth. It is considered a leading immune-mediated cause of small fiber neuropathy.
What are sphingolipids and how do they affect nerve fibers?
Certain sphingolipids are neurotoxic fats that build up in people who have metabolic syndrome. These stealth toxins can directly damage the energy centers (mitochondria) in your small nerve fibers, causing the nerves to degrade.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since my HbA1c was normal, can we perform a 2-hour Oral Glucose Tolerance Test (OGTT) to definitively rule out prediabetes?
  2. 2.Should I be tested for TS-HDS and FGFR3 autoantibodies, especially given the 'patchy' nature of my symptoms?
  3. 3.Are there specific markers for Sjögren’s Syndrome or Sarcoidosis that we haven't screened for yet?
  4. 4.If we find an autoimmune marker like TS-HDS, would I be a candidate for a trial of immunotherapy like IVIG?
  5. 5.Can we check my lipid profile for signs of metabolic syndrome, including triglyceride levels, which might relate to nerve-damaging sphingolipids?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Current Diagnosis and Treatment of Painful Small Fiber Neuropathy.

    Farhad K

    Current neurology and neuroscience reports 2019; (19(12)):103 doi:10.1007/s11910-019-1020-1.

    PMID: 31773305
  2. 2

    Small Fiber Neuropathy in the Elderly.

    Zhou L

    Clinics in geriatric medicine 2021; (37(2)):279-288 doi:10.1016/j.cger.2021.01.002.

    PMID: 33858610
  3. 3

    Implications of the use of 1-hour post-load plasma glucose value during an oral glucose tolerance test (OGTT) for the diagnosis of dysglycemia among a cohort of high-risk Thai people.

    Thewjitcharoen Y, Chatchomchuan W, Wanothayaroj E, et al.

    Diabetes research and clinical practice 2025; (222()):112056 doi:10.1016/j.diabres.2025.112056.

    PMID: 39988131
  4. 4

    Low concordance between HbA1c and OGTT to diagnose prediabetes and diabetes in overweight or obesity.

    Chatzianagnostou K, Vigna L, Di Piazza S, et al.

    Clinical endocrinology 2019; (91(3)):411-416 doi:10.1111/cen.14043.

    PMID: 31152677
  5. 5

    Deoxy-sphingolipids, oxidative stress, and vitamin C correlate with qualitative and quantitative patterns of small fiber dysfunction and degeneration.

    Dohrn MF, Dumke C, Hornemann T, et al.

    Pain 2022; (163(9)):1800-1811 doi:10.1097/j.pain.0000000000002580.

    PMID: 35239546
  6. 6

    Very long-chain fatty acids drive 1-deoxySphingolipid toxicity.

    Majcher A, Karsai G, Yusifov E, et al.

    Nature communications 2025; (16(1)):11650 doi:10.1038/s41467-025-66687-8.

    PMID: 41298489
  7. 7

    Localization of 1-deoxysphingolipids to mitochondria induces mitochondrial dysfunction.

    Alecu I, Tedeschi A, Behler N, et al.

    Journal of lipid research 2017; (58(1)):42-59 doi:10.1194/jlr.M068676.

    PMID: 27881717
  8. 8

    Small fiber neuropathy in Sjögren syndrome: Comparison with other small fiber neuropathies.

    Descamps E, Henry J, Labeyrie C, et al.

    Muscle & nerve 2020; (61(4)):515-520 doi:10.1002/mus.26824.

    PMID: 32012291
  9. 9

    Peripheral neuropathy in sarcoidosis.

    Tavee J

    Journal of neuroimmunology 2022; (368()):577864 doi:10.1016/j.jneuroim.2022.577864.

    PMID: 35585009
  10. 10

    Small Fiber Neuropathy in Sarcoidosis.

    Gavrilova N, Starshinova A, Zinchenko Y, et al.

    Pathophysiology : the official journal of the International Society for Pathophysiology 2021; (28(4)):544-550 doi:10.3390/pathophysiology28040035.

    PMID: 35366250
  11. 11

    Clinical Features and Treatment Response in Immune-Mediated Small Fiber Neuropathy with Trisulfated Heparin Disaccharide or Fibroblast Growth Factor Receptor 3 Antibodies.

    Zeidman LA, Kubicki K

    Journal of clinical neuromuscular disease 2021; (22(4)):192-199 doi:10.1097/CND.0000000000000355.

    PMID: 34019003
  12. 12

    Immune-Mediated Small Fiber Neuropathy With Trisulfated Heparin Disaccharide, Fibroblast Growth Factor Receptor 3, or Plexin D1 Antibodies: Presentation and Treatment With Intravenous Immunoglobulin.

    Zeidman LA, Saini P, Mai P

    Journal of clinical neuromuscular disease 2022; (24(1)):26-37 doi:10.1097/CND.0000000000000423.

    PMID: 36005471
  13. 13

    Cryptogenic small-fiber neuropathies: Serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3.

    Levine TD, Kafaie J, Zeidman LA, et al.

    Muscle & nerve 2020; (61(4)):512-515 doi:10.1002/mus.26748.

    PMID: 31650561
  14. 14

    A double-blind placebo-controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies.

    Gibbons CH, Rajan S, Senechal K, et al.

    Muscle & nerve 2023; (67(5)):363-370 doi:10.1002/mus.27745.

    PMID: 36367813

This page discusses potential hidden causes and advanced testing for idiopathic small fiber neuropathy for educational purposes. Always consult your neurologist before pursuing specialized testing or altering your treatment plan.

Get notified when new evidence is published on Idiopathic small fibers neuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.